Real-time monitoring of bacterial infection in vivo: Development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 9, 2003, Pages 2740-2748

  Kuklin, Nelly A ^a   Pancari, Gregory D ^a   Tobery, Timothy W ^a   Cope, Leslie ^a   Jackson, Jesse ^a   Gill, Charles ^a   Overbye, Karen ^a   Francis, Kevin P ^b   Yu, Jun ^b   Montgomery, Donna ^a   Anderson, Annaliesa S ^a   McClements, William ^a   Jansen, Kathrin U ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Xenogen Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LINEZOLID;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL INFECTION; BIOLUMINESCENCE; CATHETER INFECTION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOREIGN BODY; KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS; RELIABILITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; WOUND INFECTION;

ABSCESS; ACETAMIDES; ANIMALS; ANTI-BACTERIAL AGENTS; CATHETERIZATION; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOREIGN BODIES; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; THIGH; TIME FACTORS; WOUND INFECTION;

EID: 0042925344     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.9.2740-2748.2003     Document Type: Article

References (28)

1. Abb, J. 2002. In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method. Diagn. Microbiol. Infect. Dis. 43:319-321.
2. Allen, G. P., R. Cha, and M. J. Rybak. 2002. In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 46:2606-2612.
3. Anderegg, T. R., D. J. Biedenbach, and R. N. Jones. 2002. In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates. Antimicrob. Agents Chemother. 46:2662-2664.
4. Bergamini, T. M., R. A. Corpus, Jr., T. M. McCurry, J. C. Peyton, K. R. Brittian, and W. G. Cheadle. 1995. Immunosuppression augments growth of graft-adherent Staphylococcus epidermidis. Arch. Surg. 130:1345-1350.
5. Bunce, C., L. Wheeler, G. Reed, J. Musser, and N. Barg. 1992. Murine model of cutaneous infection with gram-positive cocci. Infect. Immun. 60:2636-2640.
6. Burns, S. M., D. Joh, K. P. Francis, X. Y. Song, C. A. Gruber, P. R. Contag, and C. H. Contag. 2001. Revealing the spatiotemporal patterns of bacterial infectious diseases using bioluminescent pathogens and whole body imaging. Anim. Test. Infect. 9:71-88.
7. Chambers, H. F. 2001. The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7:178-182.
8. Contag, C. H., P. R. Contag, J. I. Mullins, S. D. Spilman, D. K. Stevenson, and D. A. Benaron. 1995. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18:593-603.
9. Costerton, J. W., Z. Lewandowski, D. E. Caldwell, D. R. Korber, and H. M. Lappin-Scott. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745.
10. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
11. Craig, W. A., J. Redington, and S. C. Ebert. 1991. Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections. J. Antimicrob. Chemother. 27:29-40.
12. Easmon, C. S., and A. A. Glynn. 1977. Effect of cyclophosphamide on delayed hypersensitivity to Staphylococcus aureus in mice. Immunology 33:767-776.
13. Foster, T. J., and M. Hook. 1998. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 6:484-488.
14. Francis, K. P., D. Joh, C. Bellinger-Kawahara, M. J. Hawkinson, T. F. Purchio, and P. R. Contag. 2000. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect. Immun. 68:3594-3600.
15. Francis, K. P., J. Yu, C. Bellinger-Kawahara, D. Joh, M. J. Hawkinson, G. Xiao, T. F. Purchio, M. G. Caparon, M. Lipsitch, and P. R. Contag. 2001. Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect. Immun. 69:3350-3358.
16. Haddadin, A. S., S. A. Fappiano, and P. A. Lipsett. 2002. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad. Med. J. 78:385-392.
17. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532.
18. Marrie, T. J., J. Nelligan, and J. W. Costerton. 1982. A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 66:1339-1341.
19. McKenney, D., K. Pouliot, Y. Wang, V. Murthy, M. Ulrich, G. Doring, J. C. Lee, D. A. Goldmann, and G. B. Pier. 2000. Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J. Biotechnol. 83:37-44.
20. Munoz Bellido, J. L., M. N. Gutierrez Zufiaurre, F. J. Sanchez Hernandez, G. Yague Guirao, M. Segovia Hernandez, and J. A. Garcia-Rodriguez. 2002. In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents 20:61-64.
21. Rocchetta, H. L., C. J. Boylan, J. W. Foley, P. W. Iversen, D. L. LeTourneau, C. L. McMillian, P. R. Contag, D. E. Jenkins, and T. R. Parr, Jr. 2001. Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection. Antimicrob. Agents Chemother. 45:129-137.
22. Rupp, M. E., J. S. Ulphani, P. D. Fey, K. Bartscht, and D. Mack. 1999. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect. Immun. 67:2627-2632.
23. Rupp, M. E., J. S. Ulphani, P. D. Fey, and D. Mack. 1999. Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect. Immun. 67:2656-2659.
24. Sievert, D. M., G. Boulton, D. Stoltman, M. G. Johnson, F. P. Stobierski, P. A. Downes, J. T. Somsel, E. Rudrik, W. Brown, T. Hafeez, E. Lundstrom, R. Flansgan, J. Jonson, J. Mitchell, and S. Chang. 2002. Staphylococcus aureus resistant to vancomycin - United States. Morb. Mortal. Wkly. Rep. 51:565-567.
25. Snedecor, G. W., and W. G. Cochran. 1974. Statistical methods, 6th ed. Iowa State University Press, Ames.
26. Song, X. Y., F. Fox, M. A. Gallo, A. Rosenberg, R. Jordan, D. Shealy, and C. Wagner. 2002. Effects of 2 different anti-tumor necrosis factor-alpha agents in a primate model of subcutaneous abscess formation. J. Infect. Dis. 185:204-213.
27. Wenzel, R. P., and M. B. Edmond. 2001. The impact of hospital-acquired bloodstream infections. Emerg. Infect. Dis. 7:174-177.
28. Widmer, A. F., R. Frei, Z. Rajacic, and W. Zimmerli. 1990. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J. Infect. Dis. 162:96-102.